Lee Tien-Li
Chief Executive Officer
Lee Tien-Li has filed 5 SEC Form 4 filings (20 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 12, 2025.
On the most recent filing, Lee Tien-Li is listed as Chief Executive Officer at Aardvark Therapeutics, Inc. Inside the rolling window, Lee Tien-Li reported 1 open-market purchase totaling $101K in AARD and no open-market sales.
Companies traded
Other insiders at AARD
Insider Buying
$101K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 15, 2025 | AARD | Purchase | $35K |
| Sep 15, 2025 | AARD | Purchase | $62K |
| Sep 12, 2025 | AARD | Purchase | $43K |
| Sep 11, 2025 | AARD | Purchase | $47K |
| Sep 10, 2025 | AARD | Purchase | $71K |
Frequently asked questions
How many SEC Form 4 filings has Lee Tien-Li made?
Lee Tien-Li has filed 5 SEC Form 4 filings (20 transaction rows) across 1 company since 2025.
Which companies does Lee Tien-Li trade?
Lee Tien-Li has filed SEC Form 4 disclosures for 1 company, including AARD.
When was Lee Tien-Li's most recent SEC Form 4 filing?
Lee Tien-Li's most recent SEC Form 4 filing on Tracefour is dated Dec 12, 2025.
What is Lee Tien-Li's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lee Tien-Li is listed as Chief Executive Officer.
What is Lee Tien-Li's total buy and sell value in the current window?
Inside the rolling retention window, Lee Tien-Li bought $101K and sold $0 based on SEC Form 4 filings.
What was Lee Tien-Li's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 7,000 AARD shares on 2025-12-11, worth $101K, per SEC Form 4 filings.